Joshua Gardner

536 total citations
17 papers, 135 citations indexed

About

Joshua Gardner is a scholar working on Pharmacology, Immunology and Infectious Diseases. According to data from OpenAlex, Joshua Gardner has authored 17 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Joshua Gardner's work include Drug-Induced Adverse Reactions (8 papers), Asthma and respiratory diseases (3 papers) and T-cell and B-cell Immunology (3 papers). Joshua Gardner is often cited by papers focused on Drug-Induced Adverse Reactions (8 papers), Asthma and respiratory diseases (3 papers) and T-cell and B-cell Immunology (3 papers). Joshua Gardner collaborates with scholars based in United Kingdom, United States and Australia. Joshua Gardner's co-authors include Anthony A. Scalzo, Denis J. Moss, John C. Cox, Suzanne Elliott, Andreas Suhrbier, Dean J. Naisbitt, Munir Pirmohamed, Xiaoli Meng, Anna Olsson‐Brown and Monday O. Ogese and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Signal Transduction and Targeted Therapy.

In The Last Decade

Joshua Gardner

14 papers receiving 133 citations

Peers

Joshua Gardner

IMMUN

PHARM

EPIDE

ONCOL

Olajumoke Fadugba United States

BE Elewski United States

Beatrice Abrams United States

Naoki Tachibana Japan

T. Tezuka Japan

Christina Y. Lee United States

Xavier Dagenais-Lussier Canada

C. Gutgesell Germany

William Rietkerk United States

Olajumoke Fadugba United States

Joshua Gardner

31 ×0.5

IMMUN

119 ×2.6

PHARM

34 ×1.4

EPIDE

10 ×0.4

ONCOL

25 ×1.2

Citations per year, relative to Joshua Gardner Joshua Gardner (= 1×) peers Olajumoke Fadugba

Countries citing papers authored by Joshua Gardner

Since Specialization

Citations

This map shows the geographic impact of Joshua Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Gardner more than expected).

Fields of papers citing papers by Joshua Gardner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Gardner. The network helps show where Joshua Gardner may publish in the future.

Co-authorship network of co-authors of Joshua Gardner

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Gardner. A scholar is included among the top collaborators of Joshua Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Gardner. Joshua Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Gardner, Joshua, Jobst Roehmel, Paul Whitaker, et al.. (2025). Phenotypic and functional characterisation of liver-infiltrating T-cells in a case of CFTR modulator induced drug-induced liver injury. Journal of Cystic Fibrosis. 25(2). 359–368.

Sun, Lele, Pengcheng Huai, Zhenzhen Wang, et al.. (2025). TSC22 domain family member 3 links natural killer cells to CD8+ T cell-mediated drug hypersensitivity. Signal Transduction and Targeted Therapy. 10(1). 196–196.

Gardner, Joshua, Paul Thomson, Andrew Gibson, et al.. (2025). Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS. Toxicological Sciences. 206(2). 420–432.

Behan, Laura, Joshua Gardner, Mirjam Stahl, et al.. (2025). Immunogenic adverse events to CFTR modulators – An international survey. Journal of Cystic Fibrosis. 24(3). 521–525. 1 indexed citations

Gardner, Joshua, Rebecca L. Jensen, Andrew Gibson, et al.. (2024). Glycolysis: An early marker for vancomycin‐specific T‐cell activation. Clinical & Experimental Allergy. 54(1). 21–33. 3 indexed citations

Gardner, Joshua, Simon T. Abrams, Cheng‐Hock Toh, et al.. (2024). Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines. npj Vaccines. 9(1). 99–99. 6 indexed citations

Sun, Lele, Qing Zhao, Tingting Liu, et al.. (2024). Feedback regulation of VISTA and Treg by TNF‐α controls T cell responses in drug allergy. Allergy. 80(5). 1400–1416. 1 indexed citations

Almutairi, Mubarak, Adam Lister, Qing Zhao, et al.. (2023). Activation of Human CD8+ T Cells with Nitroso Dapsone–Modified HLA-B*13:01–Binding Peptides. The Journal of Immunology. 210(8). 1031–1042. 3 indexed citations

Ogese, Monday O., Adam Lister, Joshua Gardner, et al.. (2023). A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs: implications for preclinical risk assessment. Toxicological Sciences. 197(1). 38–52. 3 indexed citations

10.

Gardner, Joshua, Monday O. Ogese, Catherine J. Betts, Munir Pirmohamed, & Dean J. Naisbitt. (2022). Characterization of Teicoplanin-Specific T-Cells from Drug Naïve Donors Expressing HLA-A*32:01. Chemical Research in Toxicology. 35(2). 199–202. 4 indexed citations

11.

Olsson‐Brown, Anna, Andrew Gibson, Joshua Gardner, et al.. (2021). Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity. Toxicological Sciences. 186(1). 58–69. 27 indexed citations

12.

Olsson‐Brown, Anna, Joshua Gardner, Paul Thomson, et al.. (2021). T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab. Journal for ImmunoTherapy of Cancer. 9(5). e002521–e002521. 14 indexed citations

13.

Ogese, Monday O., Adam Lister, Joshua Gardner, et al.. (2021). Deciphering Adverse Drug Reactions:In VitroPriming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01. Toxicological Sciences. 183(1). 139–153. 17 indexed citations

14.

Gardner, Joshua. (2019). Effects of a Synthetic Clarinet Bore Liner on Spectral Centroid and Fundamental Frequency Error. Acta acustica united with Acustica. 105(6). 1206–1216. 2 indexed citations

15.

McSkimming, Brian M., et al.. (2007). Green. 791–792. 1 indexed citations

16.

Woodberry, Tonia, Joshua Gardner, Lani R. San Mateo, et al.. (1999). Immunogenicity of an HIV polytope vaccine containing multiple HLA-A2 HIV CD8+ cytotoxic T cell epitopes. Journal of Virology. 1 indexed citations

17.

Scalzo, Anthony A., Suzanne Elliott, John C. Cox, et al.. (1995). Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720). Journal of Virology. 69(2). 1306–1309. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact